2024 heart disease and stroke statistics: a report of US and global data from the American Heart Association

SS Martin, AW Aday, ZI Almarzooq, CAM Anderson… - Circulation, 2024 - ahajournals.org
BACKGROUND: The American Heart Association (AHA), in conjunction with the National
Institutes of Health, annually reports the most up-to-date statistics related to heart disease …

2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes: Developed by the task force on the management of cardiovascular …

N Marx, M Federici, K Schütt… - European heart …, 2023 - academic.oup.com
• The specific situation of the patient. Unless otherwise provided for by national regulations,
off-label use of medication should be limited to situations where it is in the patient's interest …

Global effect of modifiable risk factors on cardiovascular disease and mortality

Global Cardiovascular Risk … - New England Journal of …, 2023 - Mass Medical Soc
Background Five modifiable risk factors are associated with cardiovascular disease and
death from any cause. Studies using individual-level data to evaluate the regional and sex …

2024 ESC guidelines for the management of chronic coronary syndromes: developed by the task force for the management of chronic coronary syndromes of the …

C Vrints, F Andreotti, KC Koskinas… - European heart …, 2024 - academic.oup.com
• The specific situation of the patient. Unless otherwise provided for by national regulations,
off-label use of medication should be limited to situations where it is in the patient's interest …

2024 ESC Guidelines for the management of elevated blood pressure and hypertension: Developed by the task force on the management of elevated blood pressure …

JW McEvoy, CP McCarthy, RM Bruno… - European heart …, 2024 - academic.oup.com
• The specific situation of the patient. Unless otherwise provided for by national regulations,
off-label use of medication should be limited to situations where it is in the patient's interest …

MASLD: a systemic metabolic disorder with cardiovascular and malignant complications

G Targher, CD Byrne, H Tilg - Gut, 2024 - gut.bmj.com
Non-alcoholic fatty liver disease (NAFLD) has rapidly become the most common chronic
liver disease globally and is currently estimated to affect up to 38% of the global adult …

Development and validation of the American Heart Association's PREVENT equations

SS Khan, K Matsushita, Y Sang, SH Ballew… - Circulation, 2024 - ahajournals.org
BACKGROUND: Multivariable equations are recommended by primary prevention
guidelines to assess absolute risk of cardiovascular disease (CVD). However, current …

Gender medicine: effects of sex and gender on cardiovascular disease manifestation and outcomes

V Regitz-Zagrosek, C Gebhard - Nature Reviews Cardiology, 2023 - nature.com
Despite a growing body of evidence, the distinct contributions of biological sex and the
sociocultural dimension of gender to the manifestations and outcomes of ischaemic heart …

Metabolomic profiles predict individual multidisease outcomes

T Buergel, J Steinfeldt, G Ruyoga, M Pietzner… - Nature medicine, 2022 - nature.com
Risk stratification is critical for the early identification of high-risk individuals and disease
prevention. Here we explored the potential of nuclear magnetic resonance (NMR) …

The artificial sweetener erythritol and cardiovascular event risk

M Witkowski, I Nemet, H Alamri, J Wilcox, N Gupta… - Nature medicine, 2023 - nature.com
Artificial sweeteners are widely used sugar substitutes, but little is known about their long-
term effects on cardiometabolic disease risks. Here we examined the commonly used sugar …